Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Using finasteride with TIP extends time off period for prostate cancer patients.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Finasteride affects prostate weights and pituitary activity differently with age.

Mutations in certain receptors can cause diseases and offer new treatment options.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Modified stem cells from umbilical cord blood can make hair grow faster.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.